Tetraphase Pharmaceuticals Current Ratio 2012-2018 | TTPH

Tetraphase Pharmaceuticals current ratio from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Tetraphase Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.12B $0.02B 7.78
2018-09-30 $0.11B $0.01B 7.28
2018-06-30 $0.12B $0.01B 10.98
2018-03-31 $0.13B $0.02B 7.43
2017-12-31 $0.15B $0.02B 7.96
2017-09-30 $0.17B $0.02B 7.55
2017-06-30 $0.13B $0.02B 6.12
2017-03-31 $0.13B $0.02B 8.24
2016-12-31 $0.15B $0.01B 13.09
2016-09-30 $0.17B $0.01B 15.54
2016-06-30 $0.19B $0.01B 18.03
2016-03-31 $0.20B $0.01B 19.60
2015-12-31 $0.21B $0.01B 19.98
2015-09-30 $0.23B $0.01B 21.44
2015-06-30 $0.25B $0.02B 15.84
2015-03-31 $0.27B $0.02B 17.16
2014-12-31 $0.13B $0.02B 7.33
2014-09-30 $0.06B $0.01B 4.59
2014-06-30 $0.08B $0.02B 4.54
2014-03-31 $0.09B $0.01B 6.97
2013-12-31 $0.11B $0.01B 7.99
2013-09-30 $0.07B $0.01B 5.28
2013-06-30 $0.08B $0.01B 7.44
2013-03-31 $0.08B $0.01B 8.83
2012-12-31 $0.01B $0.01B 1.43
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.02B $0.01B 3.35
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.065B $0.019B
Tetraphase Pharmaceuticals, Inc. is a life science company engaged in developing and commercializing tetracycline based drugs to treat drug-resistant infectious diseases, inflammation, and cancer. Its principal products include eravacycline, an intravenous and oral antibiotic for the treatment of multi-drug resistant Gram-negative infections. The Company's product under development includes eravacycline oral formulation, TP-834 and TP-271. Tetraphase Pharmaceuticals, Inc. is based in Watertown, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.886B 31.19
Takeda Pharmaceutical (TAK) Japan $32.435B 12.00
Grifols (GRFS) Spain $13.064B 15.83
Ionis Pharmaceuticals (IONS) United States $10.939B 33.92
Jazz Pharmaceuticals (JAZZ) Ireland $7.812B 11.19
Neurocrine Biosciences (NBIX) United States $7.728B 500.53
Sage Therapeutics (SAGE) United States $7.480B 0.00
Tilray (TLRY) United States $6.315B 0.00
Catalent (CTLT) United States $5.892B 24.67
Nektar Therapeutics (NKTR) United States $5.636B 8.99
United Therapeutics (UTHR) United States $5.259B 8.94
FibroGen (FGEN) United States $4.539B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.207B 13.54
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.128B 21.94
Zogenix (ZGNX) United States $2.204B 0.00
PTC Therapeutics (PTCT) United States $2.183B 0.00
Portola Pharmaceuticals (PTLA) United States $2.143B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.126B 0.00
Aerie Pharmaceuticals (AERI) United States $2.069B 0.00
USANA Health Sciences (USNA) United States $2.028B 17.01
Madrigal Pharmaceuticals (MDGL) United States $2.015B 0.00
Endo (ENDP) Ireland $1.854B 2.86
Enanta Pharmaceuticals (ENTA) United States $1.846B 22.99
Heron Therapeutics (HRTX) United States $1.810B 0.00
Xencor (XNCR) United States $1.735B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.702B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.566B 135.68
Theravance Biopharma (TBPH) Cayman Islands $1.288B 0.00
Corcept Therapeutics (CORT) United States $1.263B 18.35
TherapeuticsMD (TXMD) United States $1.208B 0.00
Esperion Therapeutics (ESPR) United States $1.117B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.088B 0.00
Tricida (TCDA) United States $0.974B 0.00
Radius Health (RDUS) United States $0.843B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.825B 0.00
Dermira (DERM) United States $0.745B 0.00
ChemoCentryx (CCXI) United States $0.614B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.602B 0.00
GlycoMimetics (GLYC) United States $0.575B 0.00
Odonate Therapeutics (ODT) United States $0.569B 0.00
ArQule (ARQL) United States $0.541B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.538B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.528B 0.00
KalVista Pharmaceuticals (KALV) United States $0.508B 0.00
Collegium Pharmaceutical (COLL) United States $0.506B 0.00
Forty Seven (FTSV) United States $0.503B 0.00
Akebia Therapeutics (AKBA) United States $0.492B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.474B 27.93
Corbus Pharmaceuticals Holdings (CRBP) United States $0.467B 0.00
Siga Technologies (SIGA) United States $0.458B 0.00
Flexion Therapeutics (FLXN) United States $0.438B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.415B 0.00
Translate Bio (TBIO) United States $0.410B 0.00
OptiNose (OPTN) United States $0.394B 0.00
TCR2 THERAPTCS (TCRR) United States $0.388B 0.00
Aptorum Group (APM) China $0.379B 0.00
ImmunoGen (IMGN) United States $0.374B 0.00
Concert Pharmaceuticals (CNCE) United States $0.338B 0.00
Karyopharm Therapeutics (KPTI) United States $0.335B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.313B 11.60
Minerva Neurosciences (NERV) United States $0.303B 0.00
CASI Pharmaceuticals (CASI) United States $0.300B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.289B 0.00
Mast Therapeutics (SVRA) United States $0.287B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.285B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.282B 2.62
Xeris Pharmaceuticals (XERS) United States $0.267B 0.00
Majesco Entertainment (PTE) United States $0.261B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.254B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.248B 0.00
Aclaris Therapeutics (ACRS) United States $0.245B 0.00
HARPOON THERAPT (HARP) United States $0.244B 0.00
Dova Pharmaceuticals (DOVA) United States $0.242B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
ElectroCore (ECOR) United States $0.234B 0.00
Galectin Therapeutics (GALT) United States $0.215B 0.00
Tyme Technologies (TYME) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.212B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Ardelyx (ARDX) United States $0.205B 0.00
Molecular Templates (MTEM) United States $0.202B 0.00
Jounce Therapeutics (JNCE) United States $0.202B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.201B 0.00
Rafael Holdings (RFL) United States $0.188B 0.00
IMV INC (IMV) Canada $0.188B 0.00
Aldeyra Therapeutics (ALDX) United States $0.187B 0.00
Redhill Biopharma (RDHL) Israel $0.187B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.182B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.177B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 181.80
Ocular Therapeutix (OCUL) United States $0.170B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
Neon Therapeutics (NTGN) United States $0.146B 0.00
AgeX Therapeutics (AGE) United States $0.144B 0.00
China SXT Pharmaceuticals (SXTC) China $0.142B 0.00
Neos Therapeutics (NEOS) United States $0.142B 0.00
Recro Pharma (REPH) United States $0.141B 0.00
MediWound (MDWD) Israel $0.137B 0.00
ProNAi Therapeutics (SRRA) Canada $0.136B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.118B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Iterum Therapeutics (ITRM) Ireland $0.112B 0.00
DURECT (DRRX) United States $0.111B 0.00
Adherex Technologies (FENC) United States $0.104B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.102B 0.00
Zafgen (ZFGN) United States $0.100B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.098B 0.00
Infinity Pharmaceuticals (INFI) United States $0.097B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Avenue Therapeutics (ATXI) United States $0.091B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.086B 0.00
Otonomy (OTIC) United States $0.084B 0.00
India Globalization Capital (IGC) United States $0.082B 0.00
Natural Alternatives (NAII) United States $0.081B 7.92
SCYNEXIS (SCYX) United States $0.076B 0.00
Genocea Biosciences (GNCA) United States $0.069B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.058B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.055B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Lipocine (LPCN) United States $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Bio-Path Holdings (BPTH) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Melinta Therapeutics (MLNT) United States $0.042B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.037B 0.00
NOVAN INC (NOVN) United States $0.036B 0.00
ContraFect (CFRX) United States $0.036B 0.00
Achaogen (AKAO) United States $0.033B 0.00
HANCOCK JAFFE (HJLI) United States $0.031B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.025B 0.00
IsoRay (ISR) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Shineco (TYHT) China $0.023B 3.88
Biomerica (BMRA) United States $0.023B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.021B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
VAXART, INC (VXRT) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00